Rupee ends lower for fifth day: Falls 7 paise to 86.38 against dollar amid trade deal uncertainty; FII outflows persist
At the interbank foreign exchange market, the domestic currency opened at 86.26, touched an intra-day high of 86.22 and a low of 86.41, before settling at 86.38, down from the previous close of 86.31. This marked the rupee's fifth straight session of decline since July 16, when it had closed at 85.92.
Forex traders said while the softening of crude oil prices and a weaker dollar supported the rupee at lower levels, negative domestic equity trends and foreign institutional investor (FII) outflows capped gains.
"We expect the rupee to trade with a slight negative bias on trade deal talks. However, weakness in the American currency and softening of crude oil prices may support the rupee at lower levels," said Anuj Choudhary, Research Analyst at Mirae Asset Sharekhan.
Dilip Parmar, Research Analyst at HDFC Securities, said, 'The rupee depreciated for the fifth consecutive day, driven by risk-averse market sentiment and consistent dollar demand.'
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Lodha Panache: Hinjewadi Pune: 2/3/4 BHK Luxurious Flats
Lodha Panache
Learn More
Undo
He added, 'Regional currencies remain range-bound as the dollar consolidates amid geopolitical uncertainties. Near-term, spot USD-INR has support at 85.95 and resistance at 86.70.'
An official said the US team will visit India in August for the next round of negotiations on the proposed bilateral trade agreement. The fifth round of talks concluded last week in Washington.
The August 1 deadline marks the end of the suspension of Trump-era tariffs on several countries, including India, where a 26% tariff on exports could come into effect if no interim deal is reached.
"Traders may remain cautious ahead of PMI and durable goods orders data from the US this week," Choudhary added, noting the USD-INR spot price is expected to trade between 86.10 and 86.65.
The dollar index fell 0.03% to 97.82, while Brent crude declined 0.94% to $68.56 per barrel in futures trade.
In domestic markets, the Sensex slipped 13.53 points to 82,186.81, and the Nifty dropped 29.80 points to 25,060.90.
FIIs offloaded equities worth Rs 3,548.92 crore on a net basis, according to exchange data.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
12 minutes ago
- The Hindu
Another slip up by India in the trade pact with the U.K.
The India-United Kingdom Comprehensive Economic and Trade Agreement (CETA) raises several questions regarding India's commitments in the CETA's intellectual property chapter (Chapter 13). A problematic article in this chapter is Article 13.6, 'Understandings Regarding TRIPS and Public Health Measures', in particular its first paragraph: 'The Parties recognise the preferable and optimal route to promote and ensure access to medicines is through voluntary mechanisms, such as voluntary licensing which may include technology transfer on mutually agreed terms' ( India's agreeing to this provision would result in dilution of its position on two critical issues. First, India consistently backed the use of compulsory licensing as opposed to voluntary licensing, to address high prices of patented medicines. Second, India argued that advanced countries must transfer technologies to developing countries on 'favourable terms', for their industrialisation, and also for reducing their carbon footprints. EXPLAINED | What does the new U.K.-India trade deal entail? Issue of pricing High prices of patented medicines are a serious anomaly of the patent system, due to excessive rent-seeking by patentees. Compulsory licensing of patented medicines can vastly improve the affordability of high-priced medicines by facilitating the production of such medicines. This was experienced following the grant of compulsory licence to Natco Pharma in 2012 for producing an anti-cancer medicine, sorafenib tosylate. The price came down to less than ₹8,800 for a month's treatment, from the ₹2,80,428 charged by the owner of the patent on the medicine, Bayer Corporation ( For remedying such instances of excessive rent-seeking, India's law-makers included compulsory licensing as a key safeguard while amending the Patents Act to make it compatible with the World Trade Organization's (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). Both Houses of the Parliament unanimously adopted this legislation after a Joint Parliamentary Committee had carefully considered its provisions ( Also Read | India, U.K. sign trade deal, PMs launch new partnership framework Grant of compulsory licence India's TRIPS-consistent Patents Act allows grant of compulsory licence to anyone interested in producing a patented product in India, three years after the grant of a patent. This licence can be granted if: reasonable requirements of the public with respect to the patented invention are not satisfied; or the patented invention is not available to the public at reasonably affordable price, or the patented invention is not 'worked' in the territory of India, implying, it has not been commercially exploited in the country ( Patent rules monitor 'working' requirement and, accordingly, patentees must submit the working status of their inventions. They had to do so annually until this requirement was diluted through India's FTA with the European Free Trade Association, with India agreeing that the periodicity of reporting 'shall not be less than 3 years' ( This dilution, has now been reinforced through the CETA, and it takes away an important ground for issuing compulsory licences. By backing voluntary licensing to address the problem of access to medicines, India has, de facto, given up its position as a strong votary of compulsory licensing in the WTO. A coalition of developing countries, including India earned the right to issue compulsory licences through the Doha Declaration on the TRIPS Agreement and Public Health in 2001, despite strident opposition from advanced countries. The Declaration emphasised, 'each Member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted' ( Voluntary licences cannot ensure access to affordable medicines due to the weak bargaining position of domestic companies in developing countries vis-à-vis dominant pharmaceutical corporations. Médecins Sans Frontières (MSF), a medical humanitarian organisation, observed that using the terms of voluntary licences, pharmaceutical corporations can set various limitations, including to control the supply of active pharmaceutical ingredients, besides imposing restrictions on licensees. Therefore, options for getting affordable access are compromised when voluntary licences are used ( The MSF's observations were proven when Cipla produced the anti-COVID drug, remdesivir, in India under a voluntary licence from Gilead Sciences, the owner of the patent on the medicine. The price of remdesivir fixed by Cipla for India was, in purchasing power terms, higher than that Gilead had charged in the United States. COMMENT | The India-U.K. FTA spells a poor deal for public health India's demand will be affected The CETA undermines India's demand for technology transfer 'on favourable terms' in several multilateral forums. This demand was first made through the United Nations General Assembly Resolution on the New International Economic Order (NIEO) in 1974. A key aspect of the NIEO was the call for facilitated technology transfer from advanced to developing countries to promote the industrialisation efforts of the developing countries ( However, despite their best efforts, little progress was seen regarding technology transfer. The disappointment of developing countries was reflected in India's Fourth Biennial Update Report to the United Nations Framework Convention on Climate Change in 2024: 'Despite substantial national efforts and investments, barriers like slow international technology transfer and intellectual property rights (IPR) hinder the rapid adoption of [climate friendly] technologies' ( As India has compromised its long-held position that technology transfer to developing countries must be on 'favourable terms', its demand for climate-friendly technologies from advanced countries could lose its sting. Biswajit Dhar is former Professor of Economics at the Jawaharlal Nehru University. K.M. Gopakumar is Senior Researcher and Legal Adviser, Third World Network
&w=3840&q=100)
Business Standard
12 minutes ago
- Business Standard
Opec+ countries to boost oil production by 547,000 barrels per day
A group of countries that are part of the Opec+ alliance of oil-exporting countries has agreed to boost oil production, a move some believe could lower oil and gasoline prices, citing a steady global economic outlook and low oil inventories. The group met virtually on Sunday and announced that eight of its member countries would increase oil production by 547,000 barrels per day in September. The countries boosting output, including Saudi Arabia, Russia, Iraq, United Arab Emirates, Kuwait, Kazakhstan, Algeria and Oman, had been participating in voluntary production cuts, initially made in November 2023, which were scheduled to be phased out by September 2026. The announcement means the voluntary production cuts will end ahead of schedule. The move follows an Opec+ decision in July to boost production by 548,000 barrels per day in August. Opec said the production adjustments may be paused or reversed as market conditions evolve. When production increases, oil and gasoline prices may fall. But Brent crude oil, which is considered a global benchmark, has been trading near $70 per barrel, which could be due to a potential loss of Russian oil on the market and a large rise in crude inventories in China, according to research firm Clearview Energy Partners. President Trump has not obviously relented from his threat to sanction Russian energy if the Kremlin does not reach a peace deal with Ukraine as of August 7, potentially via secondary tariffs on buyers, Clearview Energy Partners said in an analyst note Sunday. The eight countries will meet again on September 7, Opec said in a news release.
Time of India
26 minutes ago
- Time of India
Licenses of eight krishi kendras suspended and sales halted at two over fertilizer sales irregularities
Nagpur: The licences of eight Krishi Seva Kendras (agriculture service centres) have been suspended, and sales at two others were halted due to irregularities in the sale of chemical fertilisers—urea and DAP. The action followed a probe conducted by the district agricultural superintendent. Inspections carried out by taluka-level quality control inspectors and flying squads revealed violations at several centres, including Om Ganesh, Rohit, Himanshu, Vaibhav, Mauli, and Shri Krishna Krishi Seva Kendras. Sources said the centres failed to provide satisfactory responses to the queries raised by the agriculture department. Nagpur district has 1,495 licensed Krishi Seva Kendras, all of which are being routinely inspected by full-time quality control inspectors assigned to each taluka. So far, 118 samples of chemical fertilisers have been tested, of which 16 were found to be substandard. This led to police action and the filing of 12 court cases. In addition, 1.20 metric tonnes of stock worth ₹1.35 lakh was seized. To prevent a shortage of urea in the district, a target was set to reserve 3,550 metric tonnes, of which 3,445 metric tonnes have already been secured. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Access all TV channels anywhere, anytime Techno Mag Learn More Undo This stock was released in two phases and is now available at the agricultural centres. Another 3,830 metric tonnes of urea from companies like KRIBHCO and HUFL is expected to arrive this week. District superintendent agricultural officer Ravindra Manohare said that despite 11,000 metric tonnes of urea showing as available on PoS (Point of Sale) machines, some centres were found selling fertilisers without using the machines, which led to the suspension of their licences. Manohare added that centres must display price and stock information, maintain updated stock registers, and sell fertilisers strictly through PoS machines to ensure transparency and avoid hoarding. He urged farmers to report irregularities at centres to the quality control inspector. Farmers can also contact the superintendent agricultural cfficer directly at mobile number 9420971630 or the control room at 0712-2560786. For the ongoing Kharif season, Nagpur district was allocated 42,544 metric tonnes of urea up to August 31. As of Sunday, 48,896 metric tonnes—114% of the allocation—have been supplied. Of this, 36,986 metric tonnes were sold via PoS machines, while 11,910 metric tonnes remain in stock. However, discrepancies were found between PoS records and the actual stock at some centres, prompting a special verification drive. To ensure the timely availability of quality fertilisers and to curb malpractice, the district agriculture department has activated its quality control teams. Special inspection drives have been launched, with flying squads comprising agricultural development officers, district quality control officers, and taluka inspectors actively monitoring fertiliser sales and stock. The Zilla Parishad Agriculture Department has also launched a blog to provide farmers with real-time updates on fertiliser availability across all licensed centres in the district. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
